Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S3W-01154 · Session 3

What indicators are used to quantify research investment into lung disease and whether such research investment is increased in proportion …

Answered Asked by Marilyn Livingstone Lab Lodged 18 Jun 2007

The question

To ask the Scottish Executive what indicators are used to quantify research investment into lung disease and whether such research investment is increased in proportion to the number of people affected by lung conditions.

The answer

Answered by Shona Robison on 27 Jun 2007 · 9 days after it was lodged, on time

Burden of diseaseis used as a comparator for research investment across different diseases. Thisis frequently measured in terms of disability adjusted life years (DALYs) whichmeasure the sum of life years lost due to premature mortality and years livedwith a disability adjusted for the severity and thus they take into account theimpact of mortality and morbidity in a single measure. Trends in the level ofresearch investment generally correlate with the overall trend in the DALYranking. In a recent analysis performed by the UK Clinical ResearchCollaboration (UKCRC), it was clear that for lung disease the level of researchfunding was lower than the comparative burden of disease. Further informationcan be obtained from the UKCRC website www.ukcrc.org.
Researchinvestment does not increase automatically in proportion to the number ofpeople affected by lung conditions. However, when assessing the quality ofresearch proposals, reviewers do take into account the burden and increasedprevalence of disease.

In the Official Report

No contribution in the Official Report cites S3W-01154 by reference.